Quest for the right Drug
אמפיסולבניר 1.5 גר' AMPISULVENIR 1.5 G (AMPICILLIN AS SODIUM SALT, SULBACTAM AS SODIUM SALT)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-ורידי, תוך-שרירי : I.V, I.M
צורת מינון:
אבקה להכנת תמיסה לזריקה : POWDER FOR SOLUTION FOR INJECTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Pharmaceutical particulars : מידע רוקחי
6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Not applicable 6.2 Incompatibilities This medicinal product must not be mixed with other medicinal products excepting those mentioned in section 6.6 6.3 Shelf-life The expiry date of the product is indicated on the packaging materials. After reconstitution the solution has to be used immediately and any residue should be discarded. 6.4 Special precautions for storage Below 30o C 6.5 Nature and contents of container AmpiSulVenir 1.5G is presented in the following package: - Cardboard box containing: Ampicillin/Sulbactam 1g + 500 mg powder in a 20 ml glass vial (10 powder vials) AmpiSulVenir 3G is presented in the following package: - Cardboard box containing: Ampicillin/Sulbactam 2g + 1g powder in a 20 ml glass vial (10 powder vials) 6.6 Special precaution for disposal and other handlings For AmpiSulVenir 1.5G: Intravenous use Intravenous injection: the sterile dry powder in the vial should be reconstituted with about 3 ml of water for injection and should be administered by bolus intravenous injection over at least 3 minutes, after completed dissolution (see section 4.2). Intravenous infusion: the sterile dry powder in the vial may be reconstituted with 50/100 ml of one of the compatible solutions (not water for injection) and should be administered by intravenous infusion in 15 to 30 minutes (see section 4.2). AmpiSulVenir is compatible with the following solvent solutions: • sodium chloride 9 mg/ml (0.9%) solution for infusion • sodium lactate solution • lactated Ringer’s solution • glucose 50 mg/ml (5%) solution for infusion • saccarose 100 mg/ml (10%) solution for infusion After reconstitution the solution should be used immediately and any residue should be discarded. Intramuscular use The sterile dry powder in the vial should be reconstituted with about 3 ml of water for injection or lidocaine hydrochloride 5 mg/ml (0,5%) solution (for contraindications see section 4.3). The solution should be administered by deep intramuscular injection (for contraindications see section 4.2) After reconstitution the solution should be used immediately and any residue should be discarded. The reconstituted solution should be inspected visually for particulate matter and discoloration prior to administration. The reconstituted solution is clear and colorless. For single use only. Any unused solution and the vial should be adequately disposed of, in accordance with local requirements. For AmpiSulVenir 3G: Intravenous use Intravenous injection: the sterile dry powder in the vial should be reconstituted with about 6-7 ml of water for injection and should be administered by bolus intravenous injection over at least 3 minutes, after completed dissolution (see section 4.2). Intravenous infusion: the sterile dry powder in the vial may be reconstituted with 100 ml of one of the compatible solutions (not water for injection) and should be administered by intravenous infusion in 15 to 30 minutes (see section 4.2). AmpiSulVenir is compatible with the following solvent solutions: • sodium chloride 9 mg/ml (0.9%) solution for infusion • sodium lactate solution • lactated Ringer’s solution • glucose 50 mg/ml (5%) solution for infusion • saccarose 100 mg/ml (10%) solution for infusion After reconstitution the solution should be used immediately and any residue should be discarded. Intramuscular use The sterile dry powder in the vial should be reconstituted with about 6-7 ml of water for injection or lidocaine hydrochloride 5 mg/ml (0,5%) solution (for contraindications see section 4.3). The solution should be administered by deep intramuscular injection (for contraindications see section 4.2) After reconstitution the solution should be used immediately and any residue should be discarded. The reconstituted solution should be inspected visually for particulate matter and discoloration prior to administration. The reconstituted solution is clear and colorless. For single use only. Any unused solution and the vial should be adequately disposed of, in accordance with local requirements.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לרופא
28.02.22 - עלון לרופאעלון מידע לצרכן
13.03.22 - עלון לצרכןלתרופה במאגר משרד הבריאות
אמפיסולבניר 1.5 גר'